We are live on
!
Find out more
Schroder Investment Management Group Portfolio holdings
AUM
$141B
1-Year Est. Return
34.18%
This Fund
S&P 500
This Quarter
Est. Return
-2.16%
1 Year Est. Return
+34.18%
3 Year Est. Return
+121.7%
5 Year Est. Return
+159.58%
10 Year Est. Return
+619.19%
AUM
$99.1B
AUM Growth
-$5.32B
(-5.1%)
Cap. Flow
-$740M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
27.72%
Holding
1,277
New
83
Increased
445
Reduced
587
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$927M |
| 2 |
Broadcom
AVGO
|
+$406M |
| 3 |
Blackrock
BLK
|
+$362M |
| 4 |
Carrier Global
CARR
|
+$224M |
| 5 |
Lam Research
LRCX
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$325M |
| 2 |
Tesla
TSLA
|
+$304M |
| 3 |
GE Vernova
GEV
|
+$283M |
| 4 |
NVIDIA
NVDA
|
+$280M |
| 5 |
Zebra Technologies
ZBRA
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.33% |
| 2 | Financials | 13.48% |
| 3 | Communication Services | 12.67% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Healthcare | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Aurinia Pharmaceuticals
AUPH
$2.02B
| $2.61M | ﹤0.01% |
+314,785
| New | +$2.55M |
|
852
Vanguard High Dividend Yield ETF
VYM
$84.2B
| $2.58M | ﹤0.01% |
20,039
| – | – |
|
853
HNI Corp
HNI
$3.56B
| $2.54M | ﹤0.01% |
56,785
-3,942
| -6% | -$186K |
|
854
Watsco Inc
WSO
$12.9B
| $2.49M | ﹤0.01% |
4,967
-206
| -4% | -$102K |
|
|
IPG
855
DELISTED
Interpublic Group of Companies
IPG
| $2.47M | ﹤0.01% |
94,089
-39,799
| -30% | -$1.09M |
|
856
Etsy
ETSY
$7.4B
| $2.47M | ﹤0.01% |
52,935
+8,190
| +18% | +$419K |
|
857
DXC Technology
DXC
$1.79B
| $2.45M | ﹤0.01% |
+143,152
| New | +$2.78M |
|
858
Krystal Biotech
KRYS
$9.72B
| $2.4M | ﹤0.01% |
13,048
+441
| +3% | +$74.2K |
|
859
Bath & Body Works
BBWI
$3.76B
| $2.4M | ﹤0.01% |
79,001
+21,493
| +37% | +$761K |
|
860
Boston Properties
BXP
$11B
| $2.3M | ﹤0.01% |
34,548
-69,863
| -67% | -$4.9M |
|
861
Mattel
MAT
$4.25B
| $2.28M | ﹤0.01% |
+118,346
| New | +$2.35M |
|
862
Arrowhead Research
ARWR
$12.1B
| $2.28M | ﹤0.01% |
165,122
-40,948
| -20% | -$745K |
|
863
News Corp Class A
NWSA
$15.6B
| $2.27M | ﹤0.01% |
85,188
-8,654
| -9% | -$242K |
|
864
Health Catalyst
HCAT
$132M
| $2.26M | ﹤0.01% |
496,100
-23,824
| -5% | -$126K |
|
865
Highwoods Properties
HIW
$3.51B
| $2.25M | ﹤0.01% |
77,056
-3,184
| -4% | -$92.9K |
|
866
Brown & Brown
BRO
$24B
| $2.22M | ﹤0.01% |
18,067
-529
| -3% | -$59.1K |
|
867
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $2.22M | ﹤0.01% |
57,322
+1,998
| +4% | +$75.6K |
|
868
America Movil
AMX
$69.8B
| $2.21M | ﹤0.01% |
155,459
-10,513
| -6% | -$151K |
|
869
Olema Pharmaceuticals
OLMA
$920M
| $2.19M | ﹤0.01% |
533,111
| – | – |
|
|
GTM
870
ZoomInfo Technologies
GTM
$1.25B
| $2.12M | ﹤0.01% |
+210,826
| New | +$2.21M |
|
871
AerCap
AER
$23.5B
| $2.08M | ﹤0.01% |
20,398
-3,452
| -14% | -$342K |
|
872
Mueller Industries
MLI
$14.7B
| $2.08M | ﹤0.01% |
54,280
+38,474
| +243% | +$1.54M |
|
873
Eastman Chemical
EMN
$8.43B
| $2.07M | ﹤0.01% |
23,724
+2
| +0% | +$189 |
|
874
Harmony Biosciences
HRMY
$2.24B
| $2.01M | ﹤0.01% |
+60,683
| New | +$2.18M |
|
|
TMHC
875
DELISTED
Taylor Morrison
TMHC
| $2M | ﹤0.01% |
33,403
-12,465
| -27% | -$776K |
|
Similar funds
Schroder Investment Management Group's Q1 2025 Portfolio in Review
As of Q1 2025, Schroder Investment Management Group held 1,277 positions worth $99.1B, down 5.1% from $104B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Schroder Investment Management Group's Q1 2025 filing shows 83 new, 445 increased, 587 reduced and 91 closed positions. Its largest new stake was Arista Networks: 9,143,531 shares worth $708M. The largest sale was Merck, an estimated $325M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Financials and Communication Services.
- Schroder Investment Management Group's largest Q1 2025 buy was Arista Networks: 9,143,531 shares worth $708M.
- Schroder Investment Management Group added most to Broadcom in Q1 2025, an estimated $406M increase.
- Schroder Investment Management Group's biggest Q1 2025 reduction was Merck, cutting an estimated $325M.
- Schroder Investment Management Group fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $62M.
- Schroder Investment Management Group's ten largest holdings make up 28% of its $99.1B portfolio in Q1 2025.
- Schroder Investment Management Group opened 83 new positions and closed 91 in Q1 2025.
- Schroder Investment Management Group's portfolio value fell 5.1% quarter-over-quarter to $99.1B.
Based on Schroder Investment Management Group's 13F filing for Q1 2025, filed 13 May 2025.